{"entity":{"type":"insider","cik":"0001888531","url":"/insider/0001888531","json_url":"/insider/0001888531.json","name":"Heinen Mark","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2021-12-15","last":"2024-06-10","span_basis":"filed_date"},"name_variants":[{"name":"Heinen Mark","source":"filing","n_filings":6,"first_seen":"2021-12-15","last_seen":"2024-06-10"}],"transactions":[{"id":2647982,"accession":"0001628280-24-027587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-027587","line_url":"/filing/0001628280-24-027587#line-1","is_derivative":false,"issuer_cik":"0001853070","issuer_name":"Volato Group, Inc.","issuer_ticker":"SOAR","issuer_name_source":null,"issuer_url":"/issuer/0001853070","owner_cik":"0001888531","owner_name":"Heinen Mark","owner_url":"/insider/0001888531","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8500.0,"shares_display":"8,500","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":6800.0,"total_display":"6,800.00","shares_owned_after":8500.0,"shares_owned_after_display":"8,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-06","filed_date":"2024-06-10","scope":"insider"},{"id":6914906,"accession":"0000899243-22-031045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-031045","line_url":"/filing/0000899243-22-031045#line-2","is_derivative":false,"issuer_cik":"0001832415","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001832415","owner_cik":"0001888531","owner_name":"Heinen Mark","owner_url":"/insider/0001888531","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26132.0,"shares_display":"26,132","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":50696.08,"total_display":"50,696.08","shares_owned_after":70000.0,"shares_owned_after_display":"70,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-13","filed_date":"2022-09-14","scope":"insider"},{"id":6914901,"accession":"0000899243-22-031045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-031045","line_url":"/filing/0000899243-22-031045#line-1","is_derivative":false,"issuer_cik":"0001832415","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001832415","owner_cik":"0001888531","owner_name":"Heinen Mark","owner_url":"/insider/0001888531","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23868.0,"shares_display":"23,868","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":46303.92,"total_display":"46,303.92","shares_owned_after":43868.0,"shares_owned_after_display":"43,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-14","scope":"insider"},{"id":6200491,"accession":"0000899243-22-024391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-024391","line_url":"/filing/0000899243-22-024391#line-1","is_derivative":false,"issuer_cik":"0001832415","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001832415","owner_cik":"0001888531","owner_name":"Heinen Mark","owner_url":"/insider/0001888531","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2280.605,"shares_display":"2,280.60","price_per_share":1.7539,"price_display":"1.75","price_state":"stated","total_value":3999.9531095,"total_display":"3,999.95","shares_owned_after":2280.605,"shares_owned_after_display":"2,280.60","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-28","scope":"insider"},{"id":6670263,"accession":"0000899243-22-021998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-021998","line_url":"/filing/0000899243-22-021998#line-1","is_derivative":false,"issuer_cik":"0001832415","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001832415","owner_cik":"0001888531","owner_name":"Heinen Mark","owner_url":"/insider/0001888531","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.56,"price_display":"1.56","price_state":"stated","total_value":7800.0,"total_display":"7,800.00","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-10","filed_date":"2022-06-10","scope":"insider"},{"id":6973820,"accession":"0000899243-22-013344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-013344","line_url":"/filing/0000899243-22-013344#line-1","is_derivative":false,"issuer_cik":"0001832415","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001832415","owner_cik":"0001888531","owner_name":"Heinen Mark","owner_url":"/insider/0001888531","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.98,"price_display":"1.98","price_state":"stated","total_value":9900.0,"total_display":"9,900.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-31","filed_date":"2022-04-04","scope":"insider"},{"id":4827116,"accession":"0000899243-21-048374","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-048374","line_url":"/filing/0000899243-21-048374#line-3","is_derivative":false,"issuer_cik":"0001832415","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001832415","owner_cik":"0001888531","owner_name":"Heinen Mark","owner_url":"/insider/0001888531","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2333.0,"shares_display":"2,333","price_per_share":4.695,"price_display":"4.70","price_state":"stated","total_value":10953.435,"total_display":"10,953.44","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-15","scope":"insider"},{"id":4827111,"accession":"0000899243-21-048374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-048374","line_url":"/filing/0000899243-21-048374#line-2","is_derivative":false,"issuer_cik":"0001832415","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001832415","owner_cik":"0001888531","owner_name":"Heinen Mark","owner_url":"/insider/0001888531","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":5.4424,"price_display":"5.44","price_state":"stated","total_value":2721.2,"total_display":"2,721.20","shares_owned_after":7667.0,"shares_owned_after_display":"7,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2021-12-15","scope":"insider"},{"id":4827104,"accession":"0000899243-21-048374","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-048374","line_url":"/filing/0000899243-21-048374#line-1","is_derivative":false,"issuer_cik":"0001832415","issuer_name":"Better Therapeutics, Inc.","issuer_ticker":"BTTX","issuer_name_source":null,"issuer_url":"/issuer/0001832415","owner_cik":"0001888531","owner_name":"Heinen Mark","owner_url":"/insider/0001888531","role":"Officer","officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":2725.0,"total_display":"2,725.00","shares_owned_after":7167.0,"shares_owned_after_display":"7,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001853070","name":"Volato Group, Inc.","url":"/issuer/0001853070","role":"Officer (Chief Financial Officer)","n_filings":1,"first_seen":"2024-06-10","last_seen":"2024-06-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001832415","name":"Better Therapeutics, Inc.","url":"/issuer/0001832415","role":"Officer","n_filings":5,"first_seen":"2021-12-15","last_seen":"2022-09-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001888531","retrieved_at":"2026-08-21T02:12:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}